Novel immunomic technologies for schistosome vaccine development.


Schistosomiasis remains one of the most common human helminthiases, despite the availability of an effective drug against the causative parasites. Drug treatment programmes have several limitations, and it is likely that a vaccine is required for effective control. While decades of vaccine development have seen the discovery and testing of several candidate… (More)
DOI: 10.1111/j.1365-3024.2011.01330.x


1 Figure or Table

Slides referencing similar topics